Shinko Asset Management Co., Ltd. - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 135 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is 1.93 and the average weighting 0.0%.

Quarter-by-quarter ownership
Shinko Asset Management Co., Ltd. ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2016$3,750,000
-7.1%
197,658
-21.0%
0.02%
-10.7%
Q2 2016$4,035,000
+21.6%
250,331
-9.5%
0.03%
+7.7%
Q1 2016$3,318,000
-15.7%
276,4720.0%0.03%
-25.7%
Q4 2015$3,934,000
+45.2%
276,472
+19.2%
0.04%
+34.6%
Q3 2015$2,710,000231,8620.03%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2016
NameSharesValueWeighting ↓
FRIESS ASSOCIATES LLC 97,760$3,401,0005.68%
Nantahala Capital Management 1,000,000$34,790,0001.74%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 341,294$11,874,0001.52%
Portolan Capital Management 274,889$9,563,0000.96%
Quantedge Capital Pte Ltd 121,500$4,227,0000.85%
SHAKER INVESTMENTS LLC/OH 37,117$1,291,0000.82%
GLOBEFLEX CAPITAL L P 72,253$2,514,0000.61%
EAM Investors, LLC 68,855$2,395,0000.58%
Hillsdale Investment Management Inc. 197,738$6,879,0000.55%
Capital Impact Advisors, LLC 13,835$481,0000.44%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders